ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Adc Therapeutics Sa.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04269-c3a4-7ae2-b8e2-04bbf8a50851 Created: 2026-08-27T08:50:24.544Z Duration: 2481.5803 Channels: 1 00:06:28.530 -- 00:06:30.370 Good morning, ladies and gentlemen, and welcome to 00:06:30.370 -- 00:06:31.970 the ADC Therapeutics 00:06:31.970 -- 00:06:33.250 Q4 twenty 00:06:33.250 -- 00:06:35.009 twenty five Earnings Conference Call. 00:06:36.245 -- 00:06:38.164 At this time, all lines are in listen 00:06:38.164 -- 00:06:40.565 only mode. And following the presentation, we will 00:06:40.565 -- 00:06:42.405 conduct a question and answer session. 00:06:49.080 -- 00:06:50.600 I will now turn the call over to 00:06:50.600 -- 00:06:53.080 Nicole Reilly, Head of Investor Relations 00:06:53.080 -- 00:06:56.200 and Corporate Communications for ADC Therapeutics. 00:06:56.360 -- 00:06:57.800 Nicole, please go ahead. 00:06:59.160 -- 00:07:00.600 Thank you, operator. 00:07:00.840 -- 00:07:03.265 Today, we issued a press release announcing our 00:07:03.265 -- 00:07:05.745 fourth quarter and full year twenty twenty five 00:07:05.745 -- 00:07:08.305 financial results and business updates. 00:07:08.785 -- 00:07:10.785 This release and the slides we will use 00:07:10.785 -- 00:07:13.505 in today's presentation are available on the Investors 00:07:13.505 -- 00:07:15.905 section of the ADC Therapeutics website. 00:07:16.800 -- 00:07:18.960 I'm joined on today's call by our Chief 00:07:18.960 -- 00:07:22.400 Executive Officer, Amit Malik, who will discuss our 00:07:22.400 -- 00:07:25.360 operational performance and recent business highlights, 00:07:25.680 -- 00:07:28.720 followed by our Chief Financial Officer, Pepe Carmona, 00:07:28.895 -- 00:07:31.455 who will review our fourth quarter and full 00:07:31.455 -- 00:07:32.655 ...